Management of a Complex Orbital Post-transplantation Lymphoproliferative Disorder: A Case Report and Literature Review

In Vivo. 2026 May-Jun;40(3):1824-1831. doi: 10.21873/invivo.14336.

Abstract

Background/aim: Post-transplantation lymphoproliferative disorder (PTLD) is an uncommon but serious complication of organ transplantation. Management often requires multiple treatment modalities and reduction in immunosuppressant treatment (RIT). Orbital involvement is rare, and optimal diagnostic and therapeutic approaches remain uncertain.

Case report: Here, we report a case of localized orbital PTLD that was successfully treated with RIT alone. A 62-year-old man, who had undergone kidney transplantation 18 years prior, presented with left eye pain and proptosis. Imaging revealed an enhancing intraorbital mass extending to the optic nerve and adjacent intracranial structures. Transcranial biopsy confirmed B-cell-type PTLD. The lesion regressed with stepwise RIT alone without additional therapy. The patient showed clear clinical improvement and remained in remission for more than 13 months.

Conclusion: This case suggests the potential role of a conservative, individualized, stepwise approach in selected patients with localized orbital PTLD, and may inform management strategies for other localized forms of PTLD.

Keywords: Post-transplantation lymphoproliferative disorder; kidney transplantation; orbital lymphoma; reduction in immunosuppressant treatment; transcranial biopsy.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Disease Management
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation* / adverse effects
  • Lymphoproliferative Disorders* / diagnosis
  • Lymphoproliferative Disorders* / etiology
  • Lymphoproliferative Disorders* / therapy
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Orbital Diseases* / diagnosis
  • Orbital Diseases* / etiology
  • Orbital Diseases* / therapy
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Immunosuppressive Agents